StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
59
This month
1
This year
8
Publishing Date
2024 - 04 - 12
1
2024 - 03 - 06
1
2024 - 02 - 22
1
2024 - 02 - 21
1
2024 - 02 - 15
1
2024 - 01 - 08
1
2024 - 01 - 04
1
2024 - 01 - 02
1
2023 - 10 - 24
1
2023 - 10 - 11
1
2023 - 10 - 04
1
2023 - 08 - 08
1
2023 - 05 - 11
1
2023 - 04 - 26
1
2023 - 04 - 25
1
2023 - 04 - 11
1
2023 - 03 - 24
1
2023 - 03 - 22
1
2023 - 02 - 09
1
2023 - 01 - 30
1
2023 - 01 - 03
1
2022 - 12 - 16
1
2022 - 10 - 28
2
2022 - 10 - 20
1
2022 - 09 - 07
1
2022 - 08 - 29
1
2022 - 08 - 04
1
2022 - 08 - 03
1
2022 - 07 - 27
1
2022 - 05 - 25
1
2022 - 05 - 16
1
2022 - 05 - 12
1
2022 - 05 - 11
1
2022 - 04 - 20
1
2022 - 03 - 08
1
2022 - 02 - 17
1
2022 - 02 - 15
1
2022 - 01 - 24
1
2022 - 01 - 11
1
2021 - 11 - 04
1
2021 - 10 - 28
1
2021 - 10 - 11
1
2021 - 09 - 23
1
2021 - 09 - 16
1
2021 - 09 - 15
1
2021 - 09 - 10
1
2021 - 09 - 01
1
2021 - 08 - 13
1
2021 - 08 - 09
1
2021 - 07 - 20
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 06 - 08
1
2021 - 05 - 24
1
2021 - 04 - 27
1
2021 - 04 - 20
1
2021 - 04 - 01
1
2021 - 03 - 17
1
Sector
Communications
2
Finance
3
Health technology
59
Manufacturing
2
N/a
1
Professional, scientific, and technical services
1
Tags
100
1
Abbv-951
1
Abbvie
10
Aesthetic
2
Air
1
Alliances
1
Als
1
Application
2
Atopic dermatitis
1
Awards
1
Biomidwest
6
Biotech-bay
1
Biotech-beach
2
Bla submission
1
Blood
1
Botox
1
Breast cancer
1
Cancer
2
Cd20
3
Children
1
Clinical-trials-phase-iii
4
Collaboration
2
Conference
4
Contraceptive
1
Derm
3
Dermatitis
2
Designation
1
Disease
5
Drug
4
Duobody
3
Earnings
5
Ema
2
Events
4
Eye
2
Fda
5
Financial
3
Genetown
2
Global
2
Grant
2
Growth
2
Ironwood
2
Linzess
4
Market
3
N/a
28
Parkinson
2
People
3
Pharmaceuticals
3
Phase 3
4
Positive
2
Program
2
Research
4
Results
7
Rinvoq
3
Sales
2
Skin
2
Therapeutics
3
Treatment
8
Trial
2
Ulcerative colitis
2
Year
3
Entities
3m company
43
Abb ltd
42
Abbott laboratories
60
Abbvie inc.
59
Albemarle corporation
37
Alnylam pharmaceuticals, inc.
41
Apple inc.
60
Arrival
218
Ballard power systems, inc.
41
Bank of montreal
44
Bausch health companies inc.
37
Biomarin pharmaceutical inc.
39
Black knight, inc.
129
Blackrock, inc.
37
Bristol-myers squibb company
67
Canadian imperial bank of commerce
36
Carecloud inc
41
Cisco systems, inc.
51
Conduent incorporated
79
Cybin inc
49
Duck creek technologies, inc.
52
Eli lilly and company
100
Ericsson
112
Express, inc.
37
Extreme networks, inc.
67
Fat brands inc.
37
Ford motor company
43
Fti consulting, inc.
39
Gartner, inc.
55
General electric company
41
Gilead sciences, inc.
44
Honeywell international inc.
47
Intel corporation
66
International business machines corporation
41
Jaguar health, inc.
78
Johnson & johnson
269
Kering
62
Lithium corp
58
Lpl financial holdings inc.
96
Microsoft corporation
63
Moderna, inc.
52
Morgan stanley
267
Neuronetics, inc.
39
Novo nordisk a/s
40
Omniq corp
48
Oracle corporation
66
Orange
466
Pfizer, inc.
45
Qualcomm incorporated
36
Sanofi
271
Sap se
54
Stmicroelectronics n.v.
40
Takeda pharmaceutical company limited
36
Telus corporation
36
Thermo fisher scientific inc
71
Transunion
50
Twist bioscience corporation
51
Verizon communications inc.
120
Wex inc.
64
X financial
72
Symbols
ABBV
59
ABT
1
ALKS
1
ALPMF
1
ALPMY
1
AMGN
1
ANIK
1
AZN
1
BHC
1
CERE
1
CHRS
3
CMXHF
1
CSLLY
1
CYDY
1
ENDP
1
ENDPQ
1
ENTA
1
FNCTF
2
GLAXF
1
GMAB
4
GNMSF
4
GSK
2
IMAB
1
IRWD
4
JNJ
1
MNK
1
MNKKQ
1
MNKPF
1
MS
2
NBIX
1
NVO
1
NVS
2
NVSEF
1
SMMT
1
SNY
3
SNYNF
2
TEVJF
3
UCBJF
1
UCBJY
1
VECT
1
VTRS
1
XNCR
1
Exchanges
Nasdaq
21
Nyse
59
Crawled Date
2024 - 04 - 12
1
2024 - 03 - 06
1
2024 - 02 - 22
1
2024 - 02 - 21
1
2024 - 02 - 15
1
2024 - 01 - 08
1
2024 - 01 - 04
1
2024 - 01 - 02
1
2023 - 10 - 24
1
2023 - 10 - 11
1
2023 - 10 - 04
1
2023 - 08 - 08
1
2023 - 05 - 11
1
2023 - 04 - 26
1
2023 - 04 - 25
1
2023 - 04 - 11
1
2023 - 03 - 24
1
2023 - 03 - 22
1
2023 - 02 - 09
1
2023 - 01 - 30
1
2023 - 01 - 03
1
2022 - 12 - 16
1
2022 - 10 - 28
2
2022 - 10 - 20
1
2022 - 09 - 07
1
2022 - 08 - 29
1
2022 - 08 - 04
1
2022 - 08 - 03
1
2022 - 07 - 27
1
2022 - 05 - 25
1
2022 - 05 - 16
1
2022 - 05 - 12
1
2022 - 05 - 11
1
2022 - 04 - 20
1
2022 - 03 - 08
1
2022 - 02 - 17
1
2022 - 02 - 15
1
2022 - 01 - 24
1
2022 - 01 - 11
1
2021 - 11 - 04
1
2021 - 10 - 28
1
2021 - 10 - 11
1
2021 - 09 - 23
1
2021 - 09 - 16
1
2021 - 09 - 15
1
2021 - 09 - 10
1
2021 - 09 - 01
1
2021 - 08 - 13
1
2021 - 08 - 09
1
2021 - 07 - 20
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 06 - 08
1
2021 - 05 - 24
1
2021 - 04 - 27
1
2021 - 04 - 20
1
2021 - 04 - 01
1
2021 - 03 - 17
1
Crawled Time
00:00
41
00:20
6
01:00
32
01:10
1
02:00
23
03:00
24
04:00
18
04:20
7
05:00
12
06:00
20
07:00
25
08:00
24
08:20
1
09:00
23
10:00
16
10:10
1
10:51
1
11:00
42
12:00
58
12:15
10
12:20
15
12:30
6
12:34
1
13:00
59
13:07
3
13:13
1
13:15
10
13:17
1
13:20
12
13:27
1
13:30
17
13:50
1
14:00
52
14:03
1
14:04
1
14:07
1
14:12
1
14:15
7
14:20
10
14:30
12
15:00
50
15:11
1
15:15
7
15:20
10
15:30
16
15:49
1
16:00
49
16:20
7
17:00
38
17:37
1
17:43
1
18:00
39
18:04
1
18:31
2
19:00
32
20:00
49
20:20
7
21:00
27
22:00
37
23:00
50
Source
www.biospace.com
31
www.globenewswire.com
5
www.prnewswire.com
23
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Abbvie inc.
crawled time :
13:00
save search
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published:
2024-04-12
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
1.21%
|
O:
-1.92%
H:
0.0%
C:
0.0%
qulipta
abbvie
treatment
for
migraine
AbbVie and Allergan Aesthetics to Present New Data at 2024 Annual AAD Meeting Showcasing Depth and Strength Across Dermatology and Aesthetics Portfolios
Published:
2024-03-06
(Crawled : 13:00)
- prnewswire.com
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-4.88%
|
O:
0.09%
H:
2.11%
C:
1.49%
abbvie
meeting
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology
Published:
2024-02-22
(Crawled : 13:00)
- prnewswire.com
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-3.85%
|
O:
-0.88%
H:
1.46%
C:
1.13%
abbvie
collaboration
immunology
BOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024 Grant Program Supporting Women Entrepreneurs
Published:
2024-02-21
(Crawled : 13:00)
- prnewswire.com
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-4.09%
|
O:
-0.25%
H:
0.0%
C:
0.0%
botox
women
grant
program
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Published:
2024-02-15
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-2.11%
|
O:
0.48%
H:
1.56%
C:
1.48%
IRWD
|
$8.31
3.1%
2.95%
0
|
Health Technology
|
-46.21%
|
O:
-5.63%
H:
7.34%
C:
2.81%
year
pharmaceuticals
ironwood
financial
Lutikizumab Showed Positive Results in a Phase 2 Trial of Adults with Moderate to Severe Hidradenitis Suppurativa as Program Advances to Phase 3
Published:
2024-01-08
(Crawled : 13:00)
- prnewswire.com
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
4.97%
|
O:
0.52%
H:
0.0%
C:
0.0%
positive
program
trial
results
AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call
Published:
2024-01-04
(Crawled : 13:00)
- prnewswire.com
GNMSF
|
News
|
$290.34
0.23%
3.83%
0
|
Health Technology
|
-7.71%
|
O:
0.16%
H:
1.95%
C:
1.94%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
5.21%
|
O:
-0.34%
H:
0.0%
C:
0.0%
GMAB
|
News
|
$28.56
-1.42%
-1.51%
1.1K
|
Health Technology
|
-8.34%
|
O:
1.25%
H:
0.99%
C:
0.63%
conference
abbvie
AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-02
(Crawled : 13:00)
- prnewswire.com
GNMSF
|
News
|
$290.34
0.23%
3.83%
0
|
Health Technology
|
-8.03%
|
O:
-0.78%
H:
4.49%
C:
1.55%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
9.35%
|
O:
-0.09%
H:
3.38%
C:
3.18%
GMAB
|
News
|
$28.56
-1.42%
-1.51%
1.1K
|
Health Technology
|
-10.3%
|
O:
-1.54%
H:
3.6%
C:
2.42%
CERE
|
$41.99
-0.26%
-0.26%
0
|
Finance
|
-0.97%
|
O:
-0.14%
H:
0.19%
C:
-0.31%
conference
abbvie
Allergan Aesthetics Announces Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines
Published:
2023-10-24
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
17.14%
|
O:
0.3%
H:
0.0%
C:
0.0%
positive
treatment
topline
results
AbbVie Presents Long-Term Data Further Supporting the Efficacy and Safety Profile of RINVOQ (upadacitinib) in Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Published:
2023-10-11
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
13.49%
|
O:
-0.08%
H:
0.0%
C:
0.0%
abbvie
dermatitis
rinvoq
AbbVie to Host Third-Quarter 2023 Earnings Conference Call
Published:
2023-10-04
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
14.7%
|
O:
-0.89%
H:
0.0%
C:
0.0%
conference
abbvie
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
Published:
2023-08-08
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
12.78%
|
O:
0.33%
H:
0.0%
C:
0.0%
IRWD
|
$8.31
3.1%
2.95%
0
|
Health Technology
|
-26.78%
|
O:
-3.96%
H:
0.0%
C:
-5.41%
linzess
sales
year
pharmaceuticals
ironwood
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023
Published:
2023-05-11
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
15.79%
|
O:
0.59%
H:
0.19%
C:
-0.48%
SMMT
|
$3.73
6.88%
6.18%
550
|
Health Technology
|
75.94%
|
O:
0.47%
H:
0.47%
C:
-9.62%
therapeutics
financial
results
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
Published:
2023-04-26
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
2.81%
|
O:
-1.35%
H:
0.36%
C:
-0.54%
XNCR
|
$18.37
0.88%
0.76%
480K
|
Health Technology
|
-34.58%
|
O:
-0.5%
H:
0.82%
C:
-3.72%
Enanta Pharmaceuticals Announces Sale of a Portion of Global Royalties on MAVYRET® (U.S.)/MAVIRET® (ex-U.S.) (Glecaprevir/Pibrentasvir) to OMERS Life Sciences for $200 Million
Published:
2023-04-25
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
3.33%
|
O:
0.44%
H:
0.84%
C:
0.05%
ENTA
|
$13.15
-2.16%
-2.36%
0
|
Health Technology
|
-63.84%
|
O:
1.32%
H:
0.0%
C:
-5.7%
mavyret
life
royalties
pharmaceuticals
sciences
global
Hyaluronic acid market size to grow by USD 3,719.76 million between 2022 and 2027, Growth driven by the huge requirement for safe and stable drugs that require minimal monitoring - Technavio
Published:
2023-04-11
(Crawled : 13:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
1.67%
-2.18%
0
|
Health Technology
|
-15.59%
|
O:
-1.75%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
5.12%
|
O:
0.13%
H:
0.68%
C:
-0.07%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-15.12%
|
O:
0.4%
H:
0.0%
C:
0.0%
ANIK
|
$25.79
-0.62%
-0.72%
29K
|
Health Technology
|
-8.87%
|
O:
-3.52%
H:
4.28%
C:
1.38%
growth
market
AbbVie Clinches Back-to-Back Clinical Wins in Ulcerative Colitis, Lupus
Published:
2023-03-24
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
9.17%
|
O:
-0.01%
H:
2.06%
C:
1.76%
abbvie
lupus
ulcerative colitis
AbbVie Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New Drug Application
Published:
2023-03-22
(Crawled : 13:00)
- prnewswire.com
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
8.15%
|
O:
-0.7%
H:
0.77%
C:
-1.29%
abbv-951
drug
abbvie
update
application
AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results
Published:
2023-02-09
(Crawled : 13:00)
- biospace.com/
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
17.24%
|
O:
2.69%
H:
3.5%
C:
0.13%
abbvie
financial
results
Emergency contraceptive pills market to grow by 3.72% Y-O-Y from 2022 to 2023: Rise in the number of initiatives to create awareness will drive growth -Technavio
Published:
2023-01-30
(Crawled : 13:00)
- prnewswire.com
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
15.9%
|
O:
-0.28%
H:
0.86%
C:
-0.15%
contraceptive
growth
market
← Previous
1
2
3
Next →
Gainers vs Losers
74%
26%
Top 10 Gainers
AGBA
|
$2.97
137.6%
54.87%
66M
|
Finance
RILY
|
$21.72
0.84%
32.09%
1.9M
|
Finance
HKIT
|
$1.33
30.39%
27.14%
39K
|
Technology Services
TPET
|
$0.3601
-4.51%
23.11%
11M
|
n/a
VRT
4
|
$79.17
4.08%
19.36%
6.6M
|
Electronic Technology
PEGY
|
$0.0566
23.58%
15.65%
11M
|
Manufacturing
FOA
4
|
$0.5144
-8.16%
15.43%
20
|
Finance and Insurance
BOF
|
$1.17
6.36%
14.73%
15K
|
LUCY
|
$0.2545
9.93%
13.94%
66K
|
n/a
TSLA
|
News
|
$144.68
1.85%
12.11%
6.9M
|
Consumer Durables
Your saved searches
Save your searches and get alerts when important news are released.